About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ulcerative Colitis Clinical Trials in Philadelphia | 20 Studies

Clinical Trials Ulcerative ColitisPhiladelphia

Ulcerative Colitis Clinical Trials in Philadelphia

Find 20 clinical trials for ulcerative colitis near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Ulcerative Colitis trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 20 trials

CompletedA Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisThe objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active…NCT03398148·Coronado, California and 429 others

Ulcerative Colitis Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedBalsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative ColitisTo establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with…NCT00408174·Tempe, Arizona and 87 others

RecruitingSafety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisThe purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC).NCT06850727·Birtinya and 31 others

Enrolling by invitationUtility of Random Biopsies in Patients With Inflammatory Bowel DiseaseThe proposed study is a multicenter parallel group clinical trial that will include 821 evaluable patients per group who will be randomly assigned to either high definition white…NCT06560021·Birmingham, Alabama and 20 others

Active not recruitingStudy to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).NCT05782907·Phoenix, Arizona and 88 others

Active not recruitingA Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the…NCT01848561·Birmingham, Alabama and 511 others

CompletedA Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyStudy M15-722 is a Phase 2a study to investigate the efficacy and safety of Ravagalimab (ABBV-323) in participants with moderate to severe UC who failed prior therapy.NCT03695185·Tucson, Arizona and 33 others

CompletedMethotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative ColitisThere are fewer therapeutic options for patients with active ulcerative colitis (UC) compared to patients with active Crohn's disease (CD) and the investigators are facing a…NCT01393405·Los Angeles, California and 30 others

CompletedA Study of Abatacept in Patients With Active Ulcerative ColitisThe purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active ulcerative colitis in patients who have not had an adequate response…NCT00410410·Birmingham, Alabama and 142 others

CompletedStudy of Cimzia for the Treatment of Ulcerative ColitisThe purpose of this study is to determine if Cimzia (certolizumab pegol) is an effective treatment for patients with Ulcerative colitis.NCT01090154·Philadelphia, Pennsylvania and 1 other

TerminatedTrichuris Suis Ova Treatment in Left-sided Ulcerative ColitisThe purpose of this study is to evaluate the safety and effectiveness of trichuris suis ova (TSO) in ulcerative colitis (UC).NCT01953354·Palo Alto, California and 16 others

RecruitingA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD).NCT04844606·San Francisco, California and 68 others

CompletedExploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome DisabilityEMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability.NCT06646757·Philadelphia, Pennsylvania

CompletedUse of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative ColitisThe goal of the study is to evaluate strategies that target the microbiota for the treatment of Ulcerative Colitis , This study will involve a novel diet that the investigators…NCT02345733·Philadelphia, Pennsylvania and 2 others

CompletedA Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)This study was designed to evaluate how the body processes and removes mirikizumab.NCT04004611·Orange, California and 36 others

CompletedVedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active UC or CD.NCT03138655·Los Angeles, California and 87 others

CompletedPredicting Response to Vedolizumab in Pediatric Inflammatory Bowel DiseasesVedolizumab (VDZ) is a humanized immunoglobulin G1 monoclonal antibody acting against α4β7 integrin which modulates lymphocyte trafficking in the gut.NCT02862132·Hartford, Connecticut and 14 others

Active not recruitingA Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative ColitisThe purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who responded to induction treatment with…NCT03398135·Coronado, California and 425 others

CompletedOpen-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyThe objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative…NCT00486031·Birmingham, Alabama and 94 others

CompletedMicrobiota-targeted Diet for Pediatric UCUlcerative colitis is a chronic inflammatory disease primarily involving the colon and has long been considered to be due to a dysregulated immune response targeting the colon…NCT02922881·Philadelphia, Pennsylvania

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia